Biodistribution of Photofrin II® and 5-Aminolevulinic Acid-Induced Protoporphyrin IX in Normal Rat Bladder and Bladder Tumor Models: Implications for Photodynamic Therapy
- 1 May 1998
- journal article
- Published by Wiley in Photochemistry and Photobiology
- Vol. 67 (5) , 573-583
- https://doi.org/10.1111/j.1751-1097.1998.tb09096.x
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Early clinical experience with 5‐aminolevulinic acid for the photodynamic therapy of superficial bladder cancerBritish Journal of Urology, 1996
- Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study.Gut, 1995
- Current Status of Photodynamic Therapy in OncologyDrugs, 1994
- Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancerBritish Journal of Cancer, 1994
- Selective accumulation of endogenously produced porphyrins in a liver metastasis model in ratsGastroenterology, 1992
- Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour modelBritish Journal of Cancer, 1992
- HOW DOES PHOTODYNAMIC THERAPY WORK?Photochemistry and Photobiology, 1992
- Photodynamic therapyEuropean Journal Of Cancer, 1992
- DEFINITION OF TYPE I and TYPE II PHOTOSENSITIZED OXIDATIONPhotochemistry and Photobiology, 1991
- Whole bladder photodynamic therapy for transitional cell carcinoma of bladderUrology, 1985